Tarceva - 54868-5290-0 - (erlotinib hydrochloride)

Alphabetical Index


Drug Information of Tarceva

Product NDC: 54868-5290
Proprietary Name: Tarceva
Non Proprietary Name: erlotinib hydrochloride
Active Ingredient(s): 25    mg/1 & nbsp;   erlotinib hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Tarceva

Product NDC: 54868-5290
Labeler Name: Physicians Total Care, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021743
Marketing Category: NDA
Start Marketing Date: 20050701

Package Information of Tarceva

Package NDC: 54868-5290-0
Package Description: 30 TABLET in 1 BOTTLE (54868-5290-0)

NDC Information of Tarceva

NDC Code 54868-5290-0
Proprietary Name Tarceva
Package Description 30 TABLET in 1 BOTTLE (54868-5290-0)
Product NDC 54868-5290
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name erlotinib hydrochloride
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20050701
Marketing Category Name NDA
Labeler Name Physicians Total Care, Inc.
Substance Name ERLOTINIB HYDROCHLORIDE
Strength Number 25
Strength Unit mg/1
Pharmaceutical Classes Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]

Complete Information of Tarceva


General Information